Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants.
Tripodi
Armando
A
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Dermatology, University and Foundation IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy. armando.tripodi@unimi.it
Mancuso
Maria Elisa
ME
Chantarangkul
Veena
V
Clerici
Marigrazia
M
Bader
Rossella
R
Meroni
Pier Luigi
PL
Santagostino
Elena
E
Mannucci
Pier Mannuccio
PM
D000293:Adolescent; D000328:Adult; D000368:Aged; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005169:Factor VIII / Q000032:analysis / Q000037:antagonists & inhibitors*; D005500:Follow-Up Studies; D006467:Hemophilia A / Q000097:blood* / Q000175:diagnosis; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008875:Middle Aged
D017152:Antibodies, Antiphospholipid; D016682:Lupus Coagulation Inhibitor; D005169:Factor VIII